Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Cambrian BioPharma Inc See All Filings	D/A	2025-01-13 15:33:33 UTC
Amount To Be Raised $37,602,297 Associated Brokers / Dealers N/A CIK Number 0001797409 Filed Document 0000897069-25-000101 Exclusions or Exemptions 506b Accepted Date 2025-01-13 15:33:33 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Cambrian BioPharma Inc See All Filings	D	2023-12-22 14:32:41 UTC
Amount To Be Raised $40,000,000 Associated Brokers / Dealers N/A CIK Number 0001797409 Filed Document 0000897069-23-001843 Exclusions or Exemptions 506b Accepted Date 2023-12-22 14:32:41 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Other
Cambrian BioPharma Inc See All Filings	D	2021-12-02 09:35:00 UTC
Amount To Be Raised $100,775,000 Associated Brokers / Dealers N/A CIK Number 0001797409 Filed Document 0000897069-21-000581 Exclusions or Exemptions 506b Accepted Date 2021-12-02 09:35:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Cambrian BioPharma Inc See All Filings	D	2021-05-06 12:32:32 UTC
Amount To Be Raised $28,434,938 Associated Brokers / Dealers N/A CIK Number 0001797409 Filed Document 0000897069-21-000216 Exclusions or Exemptions 506b Accepted Date 2021-05-06 12:32:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Cambrian BioPharma Inc See All Filings	D	2020-01-27 14:45:58 UTC
Amount To Be Raised $4,750,000 Associated Brokers / Dealers N/A CIK Number 0001797409 Filed Document 0000897069-20-000054 Exclusions or Exemptions 506b Accepted Date 2020-01-27 14:45:58 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity